JPRN-UMIN000029099招募中未知
Effectiveness and safety of tenofovir alafenamide for chronic hepatitis B patients - Effectiveness and safety of TAF
Toranomon branch Hospital0 个研究点目标入组 650 人开始时间: 2017年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 650
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •insufficient of clinical data
研究者
相似试验
招募中
不适用
Safety and efficacy of Tenofovir alafenamide (TAF) in patients with chronic hepatitis B and cirrhosis.Chronic hepatitis B and cirrhosisJPRN-UMIN000034362ippon Medical Chiba Hokusoh Hospital500
进行中（未招募）
1 期
Safety of tenofovir alafenamide (TAF) in patients who developed kidney toxicity while receiving tenofovir disoproxil fumarate (TDF)HIV infectionMedDRA version: 20.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-003345-29-GBKings College Hospital NHS Foundation Trust40
招募中
不适用
ong term efficacy and safety of tenofovir alafenamide fumarate (TAF) in patients with chronic hepatitis B virus(HBV) infections: an observational, non-interventional trial (TOUGH trial)B18.1Chronic viral hepatitis B without delta-agentDRKS00017414niversitätsklinikum Leipzig200
已完成
不适用
A study for correlation of molecular target gene polymorphism and pharmacokinetics of tenofovir alafenamideHepatitis BITMCTR1900002285onghua Hospital Shanghai University of Traditional Chinese Medicine
Unknown
4 期
Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis BChronic Hepatitis BMother-to-Child TransmissionSafetyEfficacyHepatitis B VirusTenofovir Alafenamide FumarateNCT04850950The First Affiliated Hospital of Zhengzhou University240